Kenta Moriwaki Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

2/2018	Establishment of an antibody specific for cancer-associated haptoglobin: a possible implication of clinical investigation.
6/2012	Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer.
12/2010	Identification of a novel type of CA19-9 carrier in human bile and sera of cancer patients: an implication of the involvement in nonsecretory exocytosis.
4/2010	Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer.
1/2010	Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test.
12/2008	Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells.
6/2006	Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenta Moriwaki Research Topics

Disease

23	Neoplasms (Cancer) 10/2023 - 06/2006
13	Inflammation (Inflammations) 01/2022 - 12/2008
9	Hepatocellular Carcinoma (Hepatoma) 10/2012 - 06/2006
8	Necrosis 09/2021 - 07/2012
7	Pancreatic Neoplasms (Pancreatic Cancer) 02/2018 - 06/2006
5	Colonic Neoplasms (Colon Cancer) 06/2022 - 06/2006
5	Neoplasm Metastasis (Metastasis) 12/2016 - 12/2006
2	Carcinogenesis 06/2012 - 07/2009
2	Liver Cirrhosis (Hepatic Cirrhosis) 06/2012 - 06/2006
1	Ovarian Neoplasms (Ovarian Cancer) 10/2023
1	Congenital Structural Myopathies (Centronuclear Myopathy) 01/2023
1	Virus Diseases (Viral Diseases) 01/2022
1	Rupture 01/2022
1	Body Weight (Weight, Body) 04/2021
1	Brain Diseases (Brain Disorder) 01/2017
1	Leukemia 03/2016
1	Wounds and Injuries (Trauma) 01/2016
1	Infections 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 06/2012
1	Fatty Liver 06/2012
1	Chronic Hepatitis (Chronic Active Hepatitis) 06/2012
1	Carcinoma (Carcinomatosis) 01/2012
1	Alzheimer Disease (Alzheimer's Disease) 12/2006
1	Stomach Neoplasms (Stomach Cancer) 06/2006

Drug/Important Bio-Agent (IBA)

12	Tumor Biomarkers (Tumor Markers)IBA 12/2016 - 06/2006
11	OligosaccharidesIBA 01/2013 - 06/2006
7	HaptoglobinsIBA 02/2018 - 06/2006
6	LigandsIBA 06/2022 - 07/2009
6	Phosphotransferases (Kinase)IBA 01/2022 - 07/2012
5	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2012
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2022 - 07/2009
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2006
5	Protein Kinases (Protein Kinase)IBA 01/2017 - 08/2013
5	LectinsIBA 06/2012 - 06/2006
4	Polysaccharides (Glycans)IBA 01/2022 - 12/2006
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2012 - 12/2007
3	CytokinesIBA 06/2022 - 04/2014
3	Death Domain ReceptorsIBA 01/2022 - 01/2015
3	EnzymesIBA 02/2018 - 06/2012
3	A-factor (Streptomyces)IBA 01/2010 - 06/2006
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 06/2022 - 09/2021
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 01/2015
2	ImmunosorbentsIBA 02/2018 - 06/2012
2	Dextrans (Dextran)FDA Link 01/2017 - 10/2014
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2017 - 10/2014
2	Guanosine Diphosphate Fucose (GDP Fucose)IBA 01/2013 - 12/2007
2	GlycosyltransferasesIBA 06/2012 - 12/2006
1	fibroblast growth factor 18IBA 10/2023
1	Dynamin IIIBA 01/2023
1	Dynamins (Dynamin)IBA 01/2023
1	ProscillaridinIBA 06/2022
1	AntibodiesIBA 06/2022
1	Cardiac GlycosidesIBA 06/2022
1	GlycosphingolipidsIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 09/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2021
1	hydroxide ionIBA 04/2021
1	pentosidineIBA 04/2021
1	Receptor-Interacting Protein Serine-Threonine KinasesIBA 01/2017
1	Monomeric GTP-Binding ProteinsIBA 01/2017
1	InterleukinsIBA 01/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2016
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 03/2016
1	Proteasome InhibitorsIBA 03/2016
1	Bortezomib (Velcade)FDA Link 03/2016
1	Caspase 8 (Caspase-8)IBA 01/2016
1	polylactosamineIBA 03/2013
1	SelectinsIBA 01/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2013
1	Fetal Proteins (Fetoprotein)IBA 10/2012
1	Amyloid (Amyloid Fibrils)IBA 07/2012
1	Coloring Agents (Dyes)IBA 07/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2012
1	alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA 06/2012
1	AsparagineIBA 06/2012
1	CholesterolIBA 06/2012
1	ProteomeIBA 07/2011
1	PhosphoproteinsIBA 07/2011
1	LipidsIBA 12/2010
1	AntigensIBA 12/2010
1	CarbohydratesIBA 12/2010
1	Caseins (Casein)FDA Link 12/2010
1	MucinsIBA 12/2010
1	pyrimidin-2-one beta-ribofuranosideIBA 10/2010
1	MethyltransferasesIBA 10/2010
1	Drug CombinationsIBA 10/2010
1	Monoclonal AntibodiesIBA 04/2010
1	Glycoproteins (Glycoprotein)IBA 01/2010
1	Neutralizing AntibodiesIBA 12/2008
1	Interleukin-6 (Interleukin 6)IBA 12/2008
1	Presenilin-1IBA 12/2006
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 12/2006
1	Flavin-Adenine Dinucleotide (FAD)IBA 12/2006
1	Conditioned Culture MediaIBA 06/2006

Therapy/Procedure

6	Therapeutics 06/2022 - 06/2008
1	Immunotherapy 01/2022
1	Transplantation 06/2012